questionText: To ask the Secretary of State for Health and Social Care, what guidance (a) his Department and (b) NHS England provide to people who are prescribed SSRIs on the risks of developing Post-SSRI Sexual Dysfunction.
answerText: The Medicines and Healthcare products Regulatory Agency (MHRA) approved product information provided to healthcare professionals and patients for all selective serotonin reuptake inhibitors (SSRIs) was updated in 2019 to inform them that reports had been ...
heading: Selective Serotonin Reuptake Inhibitors: Sexual Dysfunction